Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N9DY
|
||||
| Former ID |
DNC013604
|
||||
| Drug Name |
3-Iodoboldine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [525759] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H20INO4
|
||||
| Canonical SMILES |
CN1CCC2=C(C(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)OC)O)I
|
||||
| InChI |
1S/C19H20INO4/c1-21-5-4-10-15-12(21)6-9-7-13(22)14(24-2)8-11(9)16(15)19(25-3)18(23)17(10)20/h7-8,12,22-23H,4-6H2,1-3H3/t12-/m0/s1
|
||||
| InChIKey |
YCBIBKGMUXWRRT-LBPRGKRZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [525759] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [525759] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.